Trial Profile
A study to evaluate the long term effect of sirolimus treatment on serum levels of VEGF-D in patients with lymphangioleiomyomatosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Lymphangioleiomyomatosis
- Focus Therapeutic Use
- 19 Aug 2015 New trial record